Piper Sandler analyst James Fish upgrades$Akamai (AKAM.US)$from Neutral to Overweight and announces $93 price target.
Evercore ISI Group Upgrades Zimmer Biomet Holdings to Outperform, Raises Price Target to $148
Evercore ISI Group analyst Vijay Kumar upgrades$Zimmer Biomet Holdings (ZBH.US)$from In-Line to Outperform and raises the price target from $135 to $148.